GA10 - Endometriosis: Complete ICD-11 Coding Guide

1. Introduction

Endometriosis is a chronic gynecological condition that affects millions of women of reproductive age worldwide. It is characterized by the presence of functional endometrial tissue outside the uterine cavity, which may affect pelvic organs, peritoneum, and in rare cases, distant locations. This condition represents a significant challenge for both patients and healthcare professionals due to its complex nature, debilitating symptoms, and substantial impact on quality of life.

The clinical importance of endometriosis transcends physical symptoms. Women with this condition frequently face severe chronic pelvic pain, infertility, negative impact on interpersonal relationships, and significant reduction in work productivity. Late diagnosis, which may take years from symptom onset to confirmation, further aggravates patient suffering and increases treatment-associated costs.

From a public health perspective, endometriosis represents a considerable burden. Direct costs related to diagnostic procedures, surgical and pharmacological treatments, in addition to indirect costs associated with absenteeism and reduced work capacity, make this condition a relevant economic concern for healthcare systems globally.

Accurate coding using the GA10 code from ICD-11 is fundamental for multiple purposes: it enables appropriate epidemiological tracking, facilitates comparative international research studies, assists in healthcare resource planning, ensures appropriate reimbursement of procedures and treatments, and contributes to evidence-based public policies. Correct documentation is also essential for continuity of care when patients transition between different healthcare services or professionals.

2. Correct ICD-11 Code

Code: GA10

Description: Endometriosis

Parent category: Diseases of the female genital system

Official definition: A condition of the uterus that is frequently idiopathic. This condition is characterized by ectopic growth and function of endometrial tissue outside the uterine cavity. This condition may be associated with vestigial tissue remnants of the Wolffian or Müllerian duct, or by retrograde reflux of endometrial fragments into the peritoneal cavity during menstruation. This condition may also present with dysmenorrhea, dyspareunia, non-menstrual pelvic pain, infertility, menstrual alterations, or may be asymptomatic. Confirmation is made by laparoscopy and histological identification of ectopic fragments.

The code GA10 belongs to the chapter of conditions related to sexual and reproductive health, specifically within diseases of the female genital system. This code is used regardless of the specific location of endometriotic implants, whether in ovaries, uterosacral ligaments, pelvic peritoneum, rectovaginal septum, or other locations. ICD-11 offers subcategories under GA10 for anatomical specifications when necessary, allowing greater precision in clinical documentation.

It is important to emphasize that code GA10 should be applied only when there is adequate diagnostic confirmation, preferably through direct visualization by laparoscopy or laparotomy with histopathological confirmation. Although imaging methods such as specialized ultrasonography and magnetic resonance imaging may strongly suggest the diagnosis, histological identification remains the gold standard for definitive coding.

3. When to Use This Code

The GA10 code should be used in specific clinical scenarios where there is confirmed evidence of ectopic endometrial tissue. Below are detailed practical situations:

Scenario 1: Surgically confirmed ovarian endometriosis A 32-year-old woman presents with intense cyclic pelvic pain and an adnexal mass detected by transvaginal ultrasound, suggestive of endometrioma. During diagnostic and therapeutic laparoscopy, an ovarian cyst is identified with characteristic chocolate-colored content. Biopsy confirms the presence of endometrial glands and stroma. In this case, GA10 is the appropriate code, and may be specified with a subcategory for ovarian location.

Scenario 2: Deep infiltrative endometriosis A 38-year-old patient with a history of progressive dysmenorrhea, deep dyspareunia, and cyclic intestinal symptoms. Pelvic magnetic resonance imaging demonstrates infiltrative lesions in the rectovaginal septum and uterosacral ligaments. Laparoscopy confirms deep endometriosis with invasion of the intestinal serosa. Histopathological analysis of resected lesions confirms endometrial tissue. The GA10 code is applied, documenting the infiltrative nature of the disease.

Scenario 3: Superficial peritoneal endometriosis A 28-year-old woman investigated for primary infertility of three years' duration. During laparoscopy for fertility evaluation, multiple peritoneal implants with typical appearance are identified (powder-burn lesions, red and white vesicles). Biopsies confirm the presence of ectopic endometrial glands. GA10 is the correct code, even in the absence of significant pain symptoms.

Scenario 4: Incidentally diagnosed endometriosis A 35-year-old patient undergoing appendectomy for acute abdomen. During the procedure, the surgeon identifies suspicious lesions on the pelvic peritoneum and ovary. Anatomopathological analysis of the appendix and biopsied lesions reveals ectopic endometrial tissue. Despite the incidental diagnosis, GA10 should be coded appropriately.

Scenario 5: Endometriosis in surgical scar A 30-year-old woman with a history of cesarean delivery two years ago develops a painful nodule on the abdominal scar, with cyclic exacerbation of symptoms. Magnetic resonance imaging suggests endometriosis of the abdominal wall. Surgical excision with histopathological confirmation of endometrial tissue in the scar. GA10 is applicable for this extrapelvic location.

Scenario 6: Endometriosis associated with infertility A couple with unexplained infertility after two years of attempts. Investigation reveals minimal to mild endometriosis during laparoscopy, with histological confirmation. Even in early stages, when histologically confirmed, GA10 should be used, as the presence of ectopic endometrial tissue is documented.

4. When NOT to Use This Code

It is fundamental to distinguish situations where GA10 is not appropriate, avoiding incorrect coding:

Clinical suspicion without confirmation: When there are only symptoms suggestive of endometriosis (dysmenorrhea, dyspareunia, pelvic pain) without confirmation by direct visualization or histopathology, GA10 should not be used. In these cases, codes for specific symptoms are more appropriate until definitive investigation is performed.

Adenomyosis (GA11): Adenomyosis is characterized by the presence of endometrial tissue within the myometrium, not outside the uterus. Although it shares symptoms with endometriosis, such as dysmenorrhea and menorrhagia, it is a distinct entity. Patients with heterogeneous myometrial thickening, globular uterus, and confirmation by magnetic resonance imaging or histopathology post-hysterectomy should receive the code GA11, not GA10.

Pelvic inflammatory disorders: Pelvic inflammatory disease caused by ascending bacterial infection should not be coded as GA10. These conditions have a clear infectious etiology and require specific codes for inflammatory processes of the female genital tract.

Ovarian masses of other nature: Functional ovarian cysts, benign non-endometriotic tumors (such as cystadenomas) or malignant neoplasms should not be coded as GA10, even if they present similar symptoms. Histopathological differentiation is crucial.

Post-surgical pelvic adhesions: Adhesions resulting from previous surgeries, without evidence of endometrial tissue, should not receive code GA10. These require specific coding for post-operative complications or peritoneal adhesions.

Pelvic pain of other etiologies: Irritable bowel syndrome, interstitial cystitis, pelvic floor muscle dysfunction, or other causes of chronic pelvic pain unrelated to the presence of ectopic endometrial tissue require their specific codes.

5. Coding Step by Step

Step 1: Assess diagnostic criteria

Confirmation of endometriosis diagnosis requires specific methodology. The gold standard remains direct visualization through laparoscopy or laparotomy, with biopsy of suspected lesions and histopathological confirmation demonstrating presence of endometrial glands and stroma outside the uterine cavity.

Imaging methods can provide strong suggestive evidence. Transvaginal ultrasound with bowel preparation, performed by experienced professionals, can identify ovarian endometriomas and deep lesions. Pelvic magnetic resonance imaging is particularly useful for mapping deep infiltrative endometriosis, especially in the posterior compartment and intestinal involvement.

Detailed clinical history is fundamental: progressive dysmenorrhea unresponsive to common analgesics, deep dyspareunia, acyclic pelvic pain, cyclic intestinal or urinary symptoms, and infertility are important elements. Physical examination may reveal nodules in the pouch of Douglas, thickening of uterosacral ligaments, or adnexal masses.

Step 2: Check specifiers

After confirming the diagnosis of endometriosis, it is important to document specific characteristics that may require subcategories of code GA10:

Anatomical location: Ovarian endometriosis, peritoneal, rectovaginal septum, intestinal, bladder, or other locations should be specified when subcodes are available.

Disease extent: Although not a mandatory part of the ICD-11 code, documenting staging (classifications such as rASRM or ENZIAN) aids in therapeutic planning and prognosis.

Presence of complications: Extensive adhesions, compromise of organ function (intestinal or ureteral obstruction), or associated infertility should be documented with additional codes when applicable.

Predominant symptomatology: Identifying whether the presentation is mainly pain-related, infertility-related, or asymptomatic (incidental finding) helps in clinical contextualization.

Step 3: Differentiate from other codes

Inflammatory disorders of the female genital tract: The fundamental difference lies in etiology. Inflammatory processes generally have an identifiable infectious cause (bacterial, viral, fungal) with acute or subacute inflammatory characteristics. Endometriosis is a chronic, non-infectious condition characterized by ectopic implantation of functioning tissue. Inflammatory markers may be elevated in both, but histological confirmation clearly differentiates them.

GA11 - Adenomyosis: The critical distinction is anatomical. Adenomyosis involves invasion of the endometrium into the myometrium (uterine muscular wall), while endometriosis is characterized by endometrial tissue outside the uterus. Adenomyosis typically presents with an enlarged, globular uterus with heterogeneous myometrial thickening on imaging. Endometriosis may coexist with adenomyosis, a situation in which both codes should be applied.

Non-inflammatory disorders of the female genital tract: This category encompasses various benign conditions such as prolapses, fistulas, or non-inflammatory structural alterations. The presence of functioning ectopic endometrial tissue with histological confirmation clearly distinguishes endometriosis from these other conditions.

Step 4: Required documentation

For appropriate coding with GA10, medical documentation must include:

Mandatory checklist:

Description of symptoms presented and their temporal relationship with the menstrual cycle
Findings from gynecological physical examination
Results of imaging studies (ultrasound, magnetic resonance imaging)
Detailed surgical report describing location, appearance, and extent of lesions
Anatomopathological report confirming presence of endometrial glands and stroma
Staging when applicable
Anatomical structures involved
Presence of complications (adhesions, functional compromise)

Additional recommended elements:

History of previous treatments
Impact on fertility
Response to previous hormonal therapies
Relevant comorbidities
Proposed therapeutic planning

6. Complete Practical Example

Clinical Case:

A 34-year-old female patient, a teacher, seeks gynecological care reporting progressive pelvic pain for approximately four years. Initially, the pain manifested only during menstruation, with moderate intensity, responsive to nonsteroidal anti-inflammatory drugs. Over the past 18 months, the pain has intensified significantly, becoming incapacitating during the menstrual period, requiring work leave for 2-3 days monthly.

Additionally, the patient reports deep dyspareunia that has negatively affected her marital relationship, and episodes of pain during bowel movements during menstruation, occasionally accompanied by discrete rectal bleeding. She also reports unsuccessful conception attempts for two years, without use of contraceptive methods.

On physical examination, the patient presents with pain on palpation of the posterior cul-de-sac, with palpable nodules in the region of the uterosacral ligaments, especially on the left. Uterus in anteversion, reduced mobility, adnexa not clearly palpable due to painful sensitivity.

Specialized transvaginal ultrasound with bowel preparation demonstrates a cystic image in the left ovary measuring 4.5 cm, with low echogenicity content and diffuse internal echoes, suggestive of endometrioma. Also identified are thickening and irregularity in the retrocervical region, with possible involvement of the anterior rectal wall.

Pelvic magnetic resonance imaging confirms left ovarian endometrioma and reveals hypointense lesions on T2 in the rectovaginal septum, uterosacral ligaments bilaterally, and multiple peritoneal implants, compatible with deep infiltrative endometriosis.

After discussion with the patient regarding therapeutic options, a laparoscopic surgical approach is chosen with the objectives of confirming the diagnosis, performing complete staging, treating endometriosis, and potential improvement of fertility.

During videolaparoscopy, multiple findings are identified: left ovarian endometrioma of approximately 5 cm with typical chocolate-colored content; peritoneal implants on pelvic peritoneum, Douglas pouch, and posterior uterine surface; infiltrative lesion in the rectovaginal septum measuring approximately 3 cm, adherent to the anterior rectal wall; dense adhesions between left ovary, fallopian tube, and broad ligament; involvement of uterosacral ligaments bilaterally.

Ovarian cystectomy was performed preserving healthy ovarian tissue, resection of peritoneal implants, complete resection of the rectovaginal septum lesion with rectal shaving (without need for intestinal resection), lysis of adhesions, and restoration of pelvic anatomy. Multiple samples were sent for histopathological analysis.

Histopathological report confirms in all samples: presence of endometrial glands with columnar epithelium, surrounding endometrial stroma, hemosiderin-laden macrophages, fibrosis, and hemorrhagic alterations, compatible with endometriosis at all biopsied sites.

Step-by-Step Coding:

Analysis of criteria:

Diagnostic confirmation: Present through direct laparoscopic visualization and histopathological confirmation in multiple tissue samples.
Presence of ectopic endometrial tissue: Documented histologically in ovary, peritoneum, rectovaginal septum, and uterosacral ligaments.
Characteristic symptomatology: Progressive dysmenorrhea, deep dyspareunia, cyclic intestinal symptoms, infertility - all consistent with endometriosis.
Exclusion of alternative diagnoses: No evidence of infectious process, neoplasia, or other conditions that could explain the findings.

Code selected: GA10 - Endometriosis

Complete justification:

The code GA10 is absolutely appropriate in this case based on multiple converging factors. The patient presents with a classic clinical picture of endometriosis with progressive symptoms of pelvic pain, incapacitating dysmenorrhea, dyspareunia, and infertility. Imaging methods provided strong suggestive preoperative evidence, identifying ovarian endometrioma and deep infiltrative lesions.

Definitive confirmation came through diagnostic and therapeutic laparoscopy, where typical endometriosis lesions were directly visualized in multiple locations: ovarian (endometrioma), superficial peritoneal (implants), and deep infiltrative (rectovaginal septum, uterosacral ligaments). The macroscopic appearance of the lesions was characteristic, including the chocolate-colored content of the endometrioma and typical appearance of infiltrative lesions.

Crucially, histopathological analysis unequivocally confirmed the presence of endometrial glands and stroma in all collected samples, meeting the gold standard criterion for endometriosis diagnosis as defined by ICD-11.

Applicable complementary codes:

Additional code for female infertility associated with peritoneal/pelvic factor
Code for chronic pelvic pain if follow-up documentation indicates persistent symptomatology
Procedure code for therapeutic laparoscopy
Procedure code for ovarian cystectomy
Procedure code for deep endometriosis resection

7. Related Codes and Differentiation

Within the Same Category:

Inflammatory disorders of the female genital tract

When to use: This code is appropriate for inflammatory conditions of the female reproductive system caused by infectious agents (bacteria, viruses, fungi) or autoimmune inflammatory processes. Examples include acute pelvic inflammatory disease, salpingitis, infectious endometritis, cervicitis, vulvovaginitis.

Main difference vs. GA10: The fundamental distinction lies in etiology and pathophysiology. Inflammatory processes have an identifiable infectious or immunological cause, present with acute inflammatory markers (leukocytosis, fever, elevated C-reactive protein), respond to antibiotic therapy or anti-inflammatory agents, and do not show ectopic endometrial tissue on histology. Endometriosis is a chronic, non-infectious condition characterized by implantation and growth of functioning endometrial tissue outside the uterine cavity, with specific histological confirmation.

GA11 - Adenomyosis

When to use: Adenomyosis should be coded when there is invasion of the endometrium into the myometrium (uterine muscular layer), resulting in heterogeneous uterine thickening. Typically diagnosed by magnetic resonance imaging showing myometrial thickening, myometrial cysts, or definitively confirmed by histopathological examination of the uterus after hysterectomy.

Main difference vs. GA10: The differentiation is anatomical and clear. Adenomyosis = endometrial tissue within the muscular wall of the uterus. Endometriosis = endometrial tissue outside the uterus (ovaries, peritoneum, intestine, bladder, etc.). Both may coexist in the same patient, in which case both codes should be applied. Symptoms may overlap (dysmenorrhea, menorrhagia), but imaging and surgical findings are distinct.

Non-inflammatory disorders of the female genital tract

When to use: This category encompasses structural, functional, or degenerative non-inflammatory conditions, including genital prolapse, genitourinary or rectovaginal fistulas (not related to endometriosis), congenital anatomical alterations, scars, stenosis, or other benign conditions without inflammatory or endometriotic component.

Main difference vs. GA10: Non-inflammatory disorders represent structural or functional alterations without the presence of ectopic endometrial tissue. There is no histological confirmation of endometrial glands and stroma. The pathophysiology is completely different, involving factors such as weakening of pelvic support, obstetric trauma, hormonal changes related to menopause, or congenital malformations.

Differential Diagnoses:

Irritable bowel syndrome: May mimic cyclic intestinal symptoms of endometriosis, but there are no imaging or surgical findings of endometriotic implants, and colonoscopy/gastrointestinal examinations are normal or show only functional alterations.

Functional ovarian cysts: May cause pelvic pain and adnexal masses, but have distinct ultrasonographic characteristics, generally resolve spontaneously in 2-3 cycles, and do not present endometrial tissue on histology.

Uterine fibroids: Cause symptoms such as menorrhagia and pelvic pain, but are well-defined myometrial masses on imaging, composed of smooth muscle cells on histology, not endometrial tissue.

Pelvic inflammatory disease: Acute/subacute presentation with fever, leukocytosis, pain on cervical mobilization, response to antibiotics, without ectopic endometrial tissue.

8. Differences with ICD-10

In ICD-10, endometriosis is coded under N80, with subdivisions based primarily on anatomical location:

N80.0 - Endometriosis of the uterus
N80.1 - Endometriosis of the ovary
N80.2 - Endometriosis of the fallopian tube
N80.3 - Endometriosis of pelvic peritoneum
N80.4 - Endometriosis of rectovaginal septum and vagina
N80.5 - Endometriosis of intestine
N80.6 - Endometriosis in cutaneous scar
N80.8 - Other endometriosis
N80.9 - Endometriosis, unspecified

The transition to ICD-11 with code GA10 brings important structural changes. ICD-11 maintains the main category GA10 for endometriosis, but organizes subcategories in a more logical and clinically relevant manner, allowing better specification of multiple locations and disease characteristics.

The main practical change lies in the more flexible hierarchical structure of ICD-11, which allows more precise coding of complex presentations. While ICD-10 required selection of a primary location when multiple sites were involved, ICD-11 facilitates documentation of multifocal disease through extension specifiers.

Another relevant difference is improved integration with contemporary clinical terminology. ICD-11 more explicitly recognizes concepts such as deep infiltrating endometriosis, which has specific therapeutic and prognostic implications, whereas ICD-10 had more limited categorization.

For professionals and institutions in transition, it is important to adequately map ICD-10 codes N80.x to GA10 and appropriate subcategories in ICD-11, ensuring continuity in longitudinal patient records and consistency in epidemiological data.

9. Frequently Asked Questions

1. How is a definitive diagnosis of endometriosis made?

A definitive diagnosis of endometriosis requires histopathological confirmation of endometrial tissue (glands and stroma) in an ectopic location. The gold standard method is diagnostic laparoscopy with biopsy of suspected lesions. During the procedure, the surgeon directly visualizes endometriotic implants, which may have varied appearances: "gunpowder" lesions (black), red vesicles, white lesions, adhesions, or endometriomas (ovarian cysts with chocolate-colored content). Imaging methods such as magnetic resonance imaging and specialized ultrasonography can strongly suggest the diagnosis, especially for deep endometriosis and endometriomas, but histological confirmation remains necessary for definitive coding with GA10.

2. Can I use the GA10 code based solely on clinical symptoms?

No. The GA10 code should be reserved for cases with adequate diagnostic confirmation, preferably through surgical visualization and histopathology. Suggestive symptoms (dysmenorrhea, dyspareunia, pelvic pain) without confirmation should be coded as specific symptoms until definitive investigation is performed. This distinction is important for diagnostic accuracy, appropriate therapeutic planning, and epidemiological data integrity. Strong clinical suspicion may justify empirical treatment, but coding should reflect the level of diagnostic certainty.

3. Is treatment available in public health systems?

Treatment for endometriosis is generally available in public health systems, although accessibility and waiting times may vary significantly among different regions and countries. Therapeutic options include medical treatment (anti-inflammatory drugs, hormonal contraceptives, progestins, GnRH analogs) and surgical treatment (laparoscopy for resection or ablation of lesions). Access to specialized centers with multidisciplinary teams experienced in deep endometriosis may be more limited. Patients should consult their local health systems regarding availability, eligibility criteria, and waiting times for different therapeutic modalities.

4. How long does treatment last?

The duration of treatment varies widely depending on disease severity, symptoms, therapeutic objectives, and individual response. Medical treatment may be necessary for months to years, often continuously or intermittently for symptom control. Surgical treatment is a single event, but postoperative recovery takes weeks, and adjuvant hormonal therapy may be recommended for months after surgery. Endometriosis is a chronic condition with a tendency toward recurrence, therefore many patients require long-term management. Regular follow-up is essential to monitor therapeutic response and adjust treatment as necessary.

5. Can this code be used in medical certificates?

Yes, the GA10 code can and should be used in official medical documentation, including certificates, when appropriate. Adequate documentation of an endometriosis diagnosis is important to justify work absences during periods of intense pain, postoperative recovery, or diagnostic procedures. Certificates should include the ICD-11 code GA10, description of the diagnosis, and specification of the necessary absence period. It is important that the documentation be accurate and based on adequate diagnostic confirmation, protecting both the patient's rights and the integrity of the system.

6. Does endometriosis always cause infertility?

No. Although endometriosis is frequently associated with fertility difficulties, not all women with endometriosis experience infertility. The relationship between endometriosis and infertility is complex and multifactorial, involving pelvic anatomical distortion, adhesions, immunological alterations, reduced oocyte quality, and inflammatory peritoneal environment. Women with mild endometriosis may conceive spontaneously, while those with moderate to severe disease may have reduced fertility rates. Surgical treatment of endometriosis may improve fertility in some cases. Assisted reproductive techniques are options when spontaneous conception does not occur.

7. Can endometriosis transform into cancer?

Malignant transformation of endometriosis is rare but possible. Studies indicate a slightly increased risk of certain types of ovarian cancer (clear cell carcinoma and endometrioid carcinoma) in women with long-standing ovarian endometriosis. However, the absolute risk remains low. Appropriate surveillance and adequate treatment of endometriosis are important. Changes in clinical presentation, rapid growth of lesions, or atypical features on imaging studies should prompt further investigation. When malignancy is suspected or confirmed, specific oncological codes should be used instead of or in addition to GA10.

8. Is there a definitive cure for endometriosis?

Endometriosis is considered a chronic condition without an established definitive cure. Surgical treatment with complete resection of all visible lesions can provide prolonged symptom relief, but recurrence is common, especially in young women with years of menstruation ahead. Hysterectomy with bilateral oophorectomy (removal of uterus and ovaries) is the most definitive treatment, but is a radical option reserved for severe refractory cases in women who have completed their desired family. Suppressive hormonal therapies can effectively control symptoms while used. Natural menopause generally results in significant symptom improvement, as endometriosis is an estrogen-dependent condition.

Conclusion:

Accurate coding of endometriosis using GA10 in ICD-11 is fundamental for adequate clinical documentation, continuity of care, epidemiological research, and health resource planning. Professionals should ensure that the diagnosis is confirmed through appropriate methods, preferably surgical visualization with histopathological confirmation, before applying this code. Clear understanding of diagnostic criteria, differentiation of similar conditions, and complete documentation ensure the integrity of medical records and directly benefit the care of patients with this chronic and often debilitating condition.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Endometriosis

Compartilhar